483
Tianjin Tianyao Pharmaceuticals Co., LtdTianjin Tianyao Pharmaceuticals Co., Ltd – FDA 483, May 31, 2019
Record Details
An FDA inspection of Tianjin Tianyao Pharmaceuticals Co., Ltd in Tianjin, China, revealed significant deficiencies in their manufacturing and laboratory operations. The firm failed to follow established environmental monitoring procedures for its Class D production area and maintained inadequate stability procedures for in-process products. Additionally, laboratory records for working standards were incomplete, lacking necessary requalification testing.
View Company Profile
ID · e8d56de2-1f6d-4bda-82b3-0d99a5c0bda7
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.